Ipsen and Galderma Expand Current Distribution Agreement for Dysport® in Aesthetic Indications to Some Key Asia-Pacific Territories1
PARIS & LAUSANNE, Switzerland–(BUSINESS WIRE)– Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical company, and Galderma, a global healthcare company focused on medical solutions...